Glucagon-like peptide-1 receptor agonist may reduce incidence of diabetic retinopathy Physician's Weekly, 10 Feb 2023 1. Patients with Type 2 Diabetes taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have a lower incidence of…